Application of exogenously regulatable promoter systems to transgenic models for the study of aging

Journals of Gerontology - Series A Biological Sciences and Medical Sciences

Volumn 54, Issue 1, 1999, Pages

  Morgan, William W ^a   Richardson, Arlan ^b,c   Sharp, Z Dave ^a   Walter, Christi A ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b Mays Cancer Center at UT Health San Antonio   (United States)

^c SOUTH TEXAS VETERANS HEALTH CARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGING; ANIMAL EXPERIMENT; ARTICLE; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENETIC ANALYSIS; GENETIC TRANSCRIPTION; KNOCKOUT GENE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; TRANSGENIC MOUSE;

ANIMALIA; MUS MUSCULUS;

EID: 0032909846     PISSN: 10795006     EISSN: None     Source Type: Journal    
DOI: 10.1093/gerona/54.1.B30     Document Type: Article

References (68)

1. Ray P, Tang W, Wang P, et al. Regulated overexpression of interleukin 11 in the lung. J Clin Invest. 1997;100:2501-2511.
2. Rudnicki MA, Braun T, Hinuma S, Jaenisch R. Inactivation of MyoD in mice leads to up-regulation of the myogenic HLH gene Myf-5 and results in apparently normal muscle development. Cell. 1992;71: 383-390.
3. Rudnicki MA, Schnegelsberg PN, Stead RH, Braun T, Arnold HH, Jaenisch R. MyoD or Myf-5 is required for the formation of skeletal muscle. Cell. 1993;75:1351-1359.
4. Hu MC-T, Davidson N. The inducible lac operator-repressor system is functional in mammalian cells. Cell. 1987;48:555-566.
5. Figge J, Wright C, Collins CJ, Roberts TM, Livingston DM. Stringent regulation of stably integrated chloramphenicol acetyl transferase genes by E. coli lac repressor in monkey cells. Cell. 1988;52: 713-722.
6. Gossen M, Bonin AL, Bujard H. Control of gene activity in higher eukaryotic cells by prokaryotic regulatory elements. Trends Biochem Sci. 1993;18:471-475.
7. Lee F, Mulligan R, Berg P, Ringold G. Glucocorticoids regulate expression of dihydrofolate reductase cDNA in mouse mammary tumour virus chimaeric plasmids. Nature. 1981;294:228-232.
8. David G, Terris B, Marchio A, Lavau C, Dejean A. The acute promyelocytic leukemia PML-RAR alpha protein induces hepatic preneoplastic and neoplastic lesions in transgenic mice. Oncogene. 1997;14:1547-1554.
9. Agellon LB. Partial transfection of liver with a synthetic cholesterol 7 alpha-hydroxylase transgene is sufficient to stimulate the reduction of cholesterol in the plasma of hypercholesterolemic mice. Biochem Cell Biol. 1997;75:255-262.
10. Vallee BL, Falchuk KH. The biochemical basis of zinc physiology. Physiol Rev. 1993;73:79-117.
11. Hennig B, Toborek M, Mcclain CJ. Antiatherogenic properties of zinc: implications in endothelial cell metabolism. Nutrition. 1996; 12:711-717.
12. Porter A. Controlling your losses: conditional gene silencing in mammals. Trends Genet. 1998;14:73-79.
13. Gossen M, Bujard H. Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc Natl Acad Sci USA. 1992;89:5547-5551.
14. Degenkolb J, Takahashi M, Ellestad FA, Hillen W. Structural requirements of tetracycline-tet repressor interaction: determination of equilibrium binding constants for tetracycline analogs with the tet repressor. Antimicrob Agents Chemother. 1991;35:1591-1595.
15. Postle K, Nguyen RR, Bertrand KP. Nucleotide sequence of the repressor gene of the Tn10 tetracycline resistance determinant. Nucleic Acids Res. 1984;12:4849-4863.
16. Hillen W, Wissmann A. In: Saenger W, Heinemann U, eds. Protein-Nucleic Acid Interaction. London: Macmillan; 1989:143-162.
17. Triezenberg SJ, Kingsbury RC, McKnight SL. Functional dissection of VP16, the transactivator of herpes simplex virus immediate early gene expression. Genes Dev. 1988;2:718-729.
18. Sadowski I, Ma J, Triezenberg S, Ptashne M. GAL4-VP16 is an unusually potent transcriptional activator. Nature. 1988;335:563-564.
19. Ingles CJ, Shales M, Cress WD, Triezenberg SJ, Greenblatt J. Reduced binding of TFIID to transcriptionally compromised mutants of VP16. Nature. 1991;351:588-590.
20. Stringer KF, Ingles CJ, Greenblatt J. Direct and selective binding of an acidic transcriptional activation domain to the TATA-box factor TFIID. Nature. 1990;345:783-786.
21. Lin Y-S, Ha I, Maldonado E. Binding of general transcription factor TFIIB to an acidic activating region. Nature. 1991;353:569-571.
22. Goodrich JA, Hoey T, Thut CJ, Admon A, Tjian R. Drosophila TAFII40 interacts with both a VP16 activation domain and the basal transcription factor TFIIB. Cell. 1993;75:519-530.
23. Hillen W, Gatz C, Altschmied L, Schollmeier K, Meier I. Control of expression of the Tn10-encoded tetracycline resistance genes. J Mol Biol. 1983;169:707-721.
24. Kleinschmidt C, Tovar K, Hillen W, Porschke D. Dynamics of repressor-operator recognition: the Tn10-encoded tetracycline resistance control. Biochemistry. 1988;27:1094-1104.
25. Sopher BL, Fukuchi K, Smith AC, Leppiq KA, Furlong CE, Martin GM. Cytotoxicity mediated by conditional expression of a carboxyl-terminal derivative of the beta-amyloid precursor protein. Mol Brain Res. 1994;26:207-217.
26. Shan B, Lee WH. Deregulated expression of E2F-1 induces S-phase entry and leads to apoptosis. Mol Cell Biol. 1994;14:8166-8173.
27. Fishman GI, Kaplan ML, Buttrick PM. Tetracycline-regulated cardiac gene expression in vivo. J Clin Invest. 1994;93:1864-1868.
28. Dhawan J, Rando TA, Elson SL, Bujard H, Blau HM. Tetracycline-regulated gene expression following direct gene transfer into mouse skeletal muscle. Somat Cell Mol Genet. 1995;21:233-240.
29. Furth PA, St. Onge L, Böger J, et al. Temporal control of gene expression in transgenic mice by a tetracycline-responsive promoter. Proc Natl Acad Sci USA. 1994;91:9302-9306.
30. Ewald D, Li M, Efrat S, et al. Time-sensitive reversal of hyperplasia in transgenic mice expressing SV40 T antigen. Science. 1996;273: 1384-1386.
31. Mayford M, Bach ME, Huang Y-Y, Wang L, Hawkins RD, Kandel ER. Control of memory formation through regulated expression of a CaMKII transgene. Science. 1996;274:1678-1683.
32. Passerman RS, Fishman GI. Regulated expression of foreign genes in vivo after germline transfer. J Clin Invest. 1994;94:2421-2425.
33. Efrat S, Fusco-DeMane D, Lemberg H, Al Emran O, Wang X. Conditional transformation of a pancreatic β-cell line derived from transgenic mice expressing a tetracycline-regulated oncogene. Proc Natl Acad Sci USA. 1995;92:3576-3580.
34. Gossen M, Freundieb S, Bender G, Müller G, Hillen S, Bujard H. Transcriptional activation by tetracyclines in mammalian cells. Science. 1995;268:1766-1769.
35. No D, Yao TP, Evans RM. Ecdysone-inducible gene expression in mammalian cells and transgenic mice. Proc Natl Acad Sci USA. 1996;93:3346-3351.
36. Kistner A, Gossen M, Zimmermann F, et al. Doxycycline-mediated quantitative and tissue-specific control of gene expression in transgenic mice. Proc Natl Acad Sci USA. 1996;93:10933-10938.
37. Wang Y, O'Malley BW Jr, Tsai SY, O'Malley BW. A regulatory system for use in gene transfer. Proc Natl Acad Sci USA. 1994;91: 8180-8184.
38. Wang Y, DeMayo FJ, Tsai SY, O'Malley BW. Ligand-inducible and liver-specific target gene expression in transgenic mice. Nature Biotechnology. 1997;15:239-243.
39. Deuschle U, Meyer WKH, Thiesen H-J. Tetracycline-reversible silencing of eukaryotic promoters. Mol Cell Biol. 1995;15:1907-1914.
40. Margolin JF, Friedman JR, Meyer WKH, Vissing H, Thiesen H-J, Rauscher FJ III. Krüppel-associated boxes are potent transcriptional repression domains. Proc Natl Acad Sci USA. 1994;91:4509-4513.
41. Witzgall R, O'Leary E, Leaf A, Onaldi D, Bonventre JV. The Krüppel-associated box-A (KRAB-A) domain of zinc finger proteins mediates transcriptional repression. Proc Natl Acad Sci USA. 1994;91: 4514-4518.
42. Wang Y, Xu J, Pierson T, O'Malley BW, Tsai SY. Positive and negative regulation of gene expression in eukaryotic cells with an inducible transcriptional regulator. Gene Ther. 1997;4:432-441.
43. Schultze N, Burki Y, Lang Y, Certa U, Bluethmann H. Efficient control of gene expression by single step integration of the tetracycline system in transgenic mice. Nature Biotechnology. 1996;14:499-503.
44. Sande MA, Mandell GL. Antimicrobial agents. Tetracyclines, chloramphenicol, erthromycin, and miscellaneous antibacterial agents. In: Gilman AG, Rall TW, Nies AS, Taylor P, eds. Goodman and Gilman's The Pharmacological Basis of Therapeutics. New York: Pergamon Press; 1990:1117-1125.
45. Gu H, Marth JD, Orban PC, Mossmann H, Rajewsky K. Deletion of a DNA polymerase beta gene segment in T cells using cell type-specific gene targeting. Science. 1998;265:103-106.
46. Sobol RW, Horton JK, Kuhn R, et al. Requirement of mammalian DNA polymerase-β in base-excision repair. Nature. 1996;379: 183-186.
47. Dietz DD, Abdo LW, Haseman JK, Eustis SL, Huff JE. Comparative toxicity and carcinogenicity studies of tetracycline and oxytetracycline in rats and mice. Fundam Appl Toxicol. 1991;17:335-346.
48. Yu BP. Aging and oxidative stress: modulation by dietary restriction. Free Radic Biol Med. 1996;21:651-668.
49. Li Y, Huang TT, Carlson EJ, et al. Dilated cardiomyopathy and neonatal lethality in mutant mice lacking manganese superoxide dismutase. Nature Genet. 1995;11:376-381.
50. Heikineheim O, Haukkamaa M, Lahteenmaki P. Distribution of RU486 and its demethylated metabolites in humans. J Clin Endocrinol Metab. 1989;68:270-275.
51. Koedood M, Fichtel A, Meier P, Mitchell PJ. Human cytomegalovirus (HCMV) immediate-early enhancer promoter specificity during embryogenesis defines target tissues of congenital HCMV infection. J Virol. 1995;69:2194-2207.
52. Furth PA, Hennighausen L, Baker C, Beatty B, Woychick R. The variability in activity of the universally expressed human cytomegalovirus immediate early gene 1 enhancer/promoter in transgenic mice. Nucleic Acids Res. 1991;19:6205-6208.
53. Mikkelsen TR, Chapman B, Din N, et al. Expression of a cytomegalovirus IE-1-factor VIII cDNA hybrid gene in transgenic mice. Transgenic Res. 1992;1:164-169.
54. Sandig V, Loser P, Lieber A, Kay MA, Strauss M. HBV-derived promoters direct liver-specific expression of an adenovirally transduced LDL receptor gene. Gene Ther. 1996;3:1002-1009.
55. Descombes P, Chojkier M, Lichtsteiner S, Falvey E, Schibler U. LAP, a novel member of the C/EBP gene family, encodes a liver-enriched transcriptional activator protein. Genes Dev. 1990;4:1541-1551.
56. Talbot D, Descombes P, Schibler U. The 5′ flanking region of the rat LAP (C/EBPβ) gene can direct high-level, position-independent, copy number-dependent expression in multiple tissues in transgenic mice. Nucl Acids Res. 1994;22:756-766.
57. McBurney MW, Staines WA, Boekelheide K, Parry D, Jardine K, Pickavance L. Murine PGK-1 promoter drives widespread but not uniform expression in transgenic mice. Dev Dyn. 1994;200:278-293.
58. Martinou J-C, Dubois-Dauphin M, Staple JK, et al. Overexpression of BCL-2 in transgenic mice protects neurons from naturally occurring cell death and experimental ischemia. Neuron. 1994;13:1017-1030.
59. Bignon YJ, Chen Y, Chang CY, et al. Expression of a retinoblastoma transgene results in dwarf mice. Genes Dev. 1993;7:1654-1662.
60. Bernards R, Schackleford GM, Gerber MR, et al. Structure and expression of the murine retinoblastoma gene and characterization of its encoded protein. Proc Natl Acad Sci USA. 1989;86:6474-6478.
61. Schoenherr CJ, Anderson DJ. The neuron-restrictive silencer factor (NRSF): a coordinate repressor of multiple neuron-specific genes. Science. 1995;267:1360-1363.
62. Schoch S, Cibelli G, Thiel G. Neuron-specific gene expression of synapsin I. Major role of a negative regulatory mechanism. J Biol Chem. 1996;271:3317-3323.
63. Kawamura T, Furusaka A, Koziel MJ, et al. Transgenic expression of hepatitis C virus structural proteins in the mouse. Hepatology. 1997;25:1014-1021.
64. Yan C, Costa RH, Darnell JE Jr, Chen J, Van Dyke TA. Distinct positive and negative elements control the limited hepatocyte and choroid plexus expression of transthyretin in transgenic mice. EMBO J. 1990;9:869-878.
65. Wu H, Wade M, Krall L, Grisham J, Xiong Y, Van Dyke TA. Targeted in vivo expression of the cyclin-dependent kinase inhibitor p21 halts hepatocycte cell-cycle progression, postnatal liver development and regeneration. Genes Dev. 1996;10:245-260.
66. Shockett P, Difilippantonio M, Hellman N, Schatz DG. A modified tetracycline-regulated system provides autoregulatory, inducible gene expression in cultured cells and transgenic mice. Proc Natl Acad Sci USA. 1995;92:6522-6526.
67. Shockett PE, Schatz DG. Diverse strategies for tetracycline-regulated inducible gene expression. Proc Natl Acad Sci USA. 1996;93: 5173-5176.
68. Baron U, Gossen M, Bujard H. Tetracycline-controlled transcription in eukaryotes: novel transactivators with graded transactivation potential. Nucl Acids Res. 1997;25:2723-2729.